AAAAAA

   
Results: 1-11 |
Results: 11
PRAVASTATIN ACTIVATES ENDOTHELIAL NITRIC-OXIDE SYNTHASE INDEPENDENT OF ITS LIPID-LOWERING ACTIONS
Authors: KAESEMEYER WH CALDWELL RB TAYLOR TA HUANG J CALDWELL RW
Citation: Wh. Kaesemeyer et al., PRAVASTATIN ACTIVATES ENDOTHELIAL NITRIC-OXIDE SYNTHASE INDEPENDENT OF ITS LIPID-LOWERING ACTIONS, The FASEB journal, 12(4), 1998, pp. 581-581
EFFECT OF NITRIC-OXIDE DONORS AND SYNTHASE AGONIST PEPTIDES ON ENDOTHELIAL-CELL UPTAKE OF L-ARGININE
Authors: OGONOWSKI AA KAESEMEYER WH LEIBACH FG GANAPATHY V ANDREWS B CALDWELL RW
Citation: Aa. Ogonowski et al., EFFECT OF NITRIC-OXIDE DONORS AND SYNTHASE AGONIST PEPTIDES ON ENDOTHELIAL-CELL UPTAKE OF L-ARGININE, The FASEB journal, 12(4), 1998, pp. 2568-2568
PRAVASTATIN ACTIVATES ENDOTHELIAL NITRIC-OXIDE SYNTHASE INDEPENDENT OF ITS LIPID-LOWERING ACTIONS
Authors: KAESEMEYER WH CALDWELL RB TAYLOR TA HUANG J CALDWELL RW
Citation: Wh. Kaesemeyer et al., PRAVASTATIN ACTIVATES ENDOTHELIAL NITRIC-OXIDE SYNTHASE INDEPENDENT OF ITS LIPID-LOWERING ACTIONS, Journal of the American College of Cardiology, 31(2), 1998, pp. 53-53
EFFECT OF NITRIC-OXIDE DONORS AND SYNTHASE AGONIST PEPTIDES ON ENDOTHELIAL-CELL UPTAKE OF L-ARGININE
Authors: OGONOWSKI AA KAESEMEYER WH LEIBACH FH GANAPATHY V ANDREWS B CALDWELL RW
Citation: Aa. Ogonowski et al., EFFECT OF NITRIC-OXIDE DONORS AND SYNTHASE AGONIST PEPTIDES ON ENDOTHELIAL-CELL UPTAKE OF L-ARGININE, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 320-320
PRAVASTATIN ACTIVATES ENDOTHELIAL NITRIC-OXIDE SYNTHASE INDEPENDENT OF ITS LIPID-LOWERING ACTIONS
Authors: KAESEMEYER WH CALDWELL RB TAYLOR TA HUANG J CALDWELL RW
Citation: Wh. Kaesemeyer et al., PRAVASTATIN ACTIVATES ENDOTHELIAL NITRIC-OXIDE SYNTHASE INDEPENDENT OF ITS LIPID-LOWERING ACTIONS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 1881-1881
NITRATES SUPPLEMENTED WITH L-ARGININE FOR THE REVERSAL AND TREATMENT OF NITRATE TOLERANCE - 2 CASE-REPORTS
Authors: KAESEMEYER WH ABOUMOHAMED G CRUTE TD CALDWELL RW
Citation: Wh. Kaesemeyer et al., NITRATES SUPPLEMENTED WITH L-ARGININE FOR THE REVERSAL AND TREATMENT OF NITRATE TOLERANCE - 2 CASE-REPORTS, ACP. Applied cardiopulmonary pathophysiology, 6(4), 1996, pp. 255-262
L-ARGININE IN THE DEVELOPMENT AND REVERSAL OF TOLERANCE TO NITROGLYCERIN
Authors: ABOUMOHAMED G SUAREZ A KAESEMEYER WH PAPAPETROPOULOS A CATRAVAS JD CALDWELL RW
Citation: G. Aboumohamed et al., L-ARGININE IN THE DEVELOPMENT AND REVERSAL OF TOLERANCE TO NITROGLYCERIN, The FASEB journal, 10(3), 1996, pp. 3280-3280
NITROGLYCERIN (NTG), BUT NOT SODIUM-NITROPRUSSIDE (SNP), INCREASES AORTIC RING CGMP LEVELS VIA AN L-ARGININE DEPENDENT AND L-NAME SENSITIVEPATHWAY
Authors: ABOUMOHAMED G KAESEMEYER WH PAPAPETROPOULOS A CATRAVAS JD CALDWELL RW
Citation: G. Aboumohamed et al., NITROGLYCERIN (NTG), BUT NOT SODIUM-NITROPRUSSIDE (SNP), INCREASES AORTIC RING CGMP LEVELS VIA AN L-ARGININE DEPENDENT AND L-NAME SENSITIVEPATHWAY, The FASEB journal, 9(3), 1995, pp. 327-327
VERAPAMIL AND NIFEDIPINE IN COMBINATION FOR THE TREATMENT OF HYPERTENSION
Authors: KAESEMEYER WH CARR AA BOTTINI PB PRISANT LH
Citation: Wh. Kaesemeyer et al., VERAPAMIL AND NIFEDIPINE IN COMBINATION FOR THE TREATMENT OF HYPERTENSION, Journal of clinical pharmacology, 34(1), 1994, pp. 48-51
HOLDING SMOKERS ACCOUNTABLE FOR HEART-DISEASE COSTS
Authors: KAESEMEYER WH
Citation: Wh. Kaesemeyer, HOLDING SMOKERS ACCOUNTABLE FOR HEART-DISEASE COSTS, Circulation, 90(2), 1994, pp. 1029-1032
SURVIVAL AFTER CONGESTIVE-HEART-FAILURE IN FRAMINGHAM HEART-STUDY SUBJECTS
Authors: KAESEMEYER WH
Citation: Wh. Kaesemeyer, SURVIVAL AFTER CONGESTIVE-HEART-FAILURE IN FRAMINGHAM HEART-STUDY SUBJECTS, Circulation, 89(1), 1994, pp. 506-506
Risultati: 1-11 |